$BURU
Nuburu, Inc.

2022 Q1 Form 10-Q Financial Statement

#000110465922061335 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $555.1K
YoY Change
Gross Profit -$465.1K
YoY Change
Gross Profit Margin
Selling, General & Admin $1.192M $2.804M
YoY Change -57.49%
% of Gross Profit
Research & Development $631.5K
YoY Change
% of Gross Profit
Depreciation & Amortization $135.2K
YoY Change
% of Gross Profit
Operating Expenses $249.9K $2.804M
YoY Change -91.09%
Operating Profit -$249.9K -$2.804M
YoY Change -91.09%
Interest Expense $174.1K $50.18K
YoY Change 246.95%
% of Operating Profit
Other Income/Expense, Net $9.418M $10.09M
YoY Change -6.63%
Pretax Income $9.168M $7.283M
YoY Change 25.89%
Income Tax $6.493K
% Of Pretax Income 0.07%
Net Earnings $9.161M $7.283M
YoY Change 25.8%
Net Earnings / Revenue
Basic Earnings Per Share -$0.44
Diluted Earnings Per Share $219.3K $174.3K
COMMON SHARES
Basic Shares Outstanding 5.209M
Diluted Shares Outstanding 5.209M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $325.5K $1.958M
YoY Change -83.38%
Cash & Equivalents $325.5K $1.958M
Short-Term Investments
Other Short-Term Assets $65.63K $227.3K
YoY Change -71.12%
Inventory
Prepaid Expenses $65.63K
Receivables $223.3K
Other Receivables
Total Short-Term Assets $391.1K $2.185M
YoY Change -82.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $334.6M $334.4M
YoY Change 0.07%
Other Assets
YoY Change
Total Long-Term Assets $334.6M $334.4M
YoY Change 0.07%
TOTAL ASSETS
Total Short-Term Assets $391.1K $2.185M
Total Long-Term Assets $334.6M $334.4M
Total Assets $335.0M $336.6M
YoY Change -0.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.917M
YoY Change
Accrued Expenses $4.026M $2.801M
YoY Change 43.7%
Deferred Revenue $173.1K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.032M $2.801M
YoY Change 43.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $16.19M $38.64M
YoY Change -58.1%
Total Long-Term Liabilities $16.19M $38.64M
YoY Change -58.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.032M $2.801M
Total Long-Term Liabilities $16.19M $38.64M
Total Liabilities $20.22M $41.44M
YoY Change -51.21%
SHAREHOLDERS EQUITY
Retained Earnings -$19.43M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.43M -$39.10M
YoY Change
Total Liabilities & Shareholders Equity $335.0M $336.6M
YoY Change -0.46%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $9.161M $7.283M
YoY Change 25.8%
Depreciation, Depletion And Amortization $135.2K
YoY Change
Cash From Operating Activities -$154.2K -$271.0K
YoY Change -43.09%
INVESTING ACTIVITIES
Capital Expenditures $102.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$102.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -17.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -154.2K -271.0K
Cash From Investing Activities -102.4K
Cash From Financing Activities 0.000 -17.00K
Net Change In Cash -154.2K -288.0K
YoY Change -46.45%
FREE CASH FLOW
Cash From Operating Activities -$154.2K -$271.0K
Capital Expenditures $102.4K
Free Cash Flow -$256.6K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001814215
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 twnd Threshold Trading Days For Redeem Public Shares After Completion Of Initial Business Combination
ThresholdTradingDaysForRedeemPublicSharesAfterCompletionOfInitialBusinessCombination
P10D
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39489
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
TAILWIND ACQUISITION CORP.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1545 Courtney Ave
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90046
CY2022Q1 dei City Area Code
CityAreaCode
646
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
432-0610
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
325463
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479694
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
65625
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
111667
CY2022Q1 us-gaap Assets Current
AssetsCurrent
391088
CY2021Q4 us-gaap Assets Current
AssetsCurrent
591361
CY2022Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334615298
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334441194
CY2022Q1 us-gaap Assets
Assets
335006386
CY2021Q4 us-gaap Assets
Assets
335032555
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3916751
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3867106
CY2022Q1 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2021Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6493
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4032244
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3976106
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
4489833
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
13733608
CY2022Q1 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2021Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2022Q1 us-gaap Liabilities
Liabilities
20219627
CY2021Q4 us-gaap Liabilities
Liabilities
29407264
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19429777
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28591245
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-19428941
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335006386
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335032555
CY2022Q1 twnd Formation And Operating Costs
FormationAndOperatingCosts
249918
CY2021Q1 twnd Formation And Operating Costs
FormationAndOperatingCosts
2803713
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-249918
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2803713
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
174104
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
50175
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9243775
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10036098
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9417879
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10086273
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9167961
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7282560
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6493
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9161468
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7282560
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9161468
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-19428941
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7282560
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-39097337
CY2022Q1 us-gaap Profit Loss
ProfitLoss
9161468
CY2021Q1 us-gaap Profit Loss
ProfitLoss
7282560
CY2022Q1 twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-9243775
CY2021Q1 twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-10036098
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
174104
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
50175
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-46042
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-48360
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
49645
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2484340
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6493
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-154231
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-271013
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-154231
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-288013
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479694
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325463
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1957785
CY2022Q1 twnd Percentage Of Aggregate Fair Market Value Of Asset
PercentageOfAggregateFairMarketValueOfAsset
0.80
CY2022Q1 twnd Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum
BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum
0.50
CY2022Q1 twnd Per Share Value Of Residual Assets Remaining Available For Distribution Which Is Held In Trust Account
PerShareValueOfResidualAssetsRemainingAvailableForDistributionWhichIsHeldInTrustAccount
10.00
CY2022Q1 twnd Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001
CY2022Q1 twnd Redemption Of Percentage Of Common Stock Included In Units Sold In Offering
RedemptionOfPercentageOfCommonStockIncludedInUnitsSoldInOffering
0.15
CY2022Q1 twnd Obligation To Redeem Percentage Of Common Stock With Respect To Any Other Material Provision Relating To Stockholders Rights Or Pre Initial Business Combination Activity
ObligationToRedeemPercentageOfCommonStockWithRespectToAnyOtherMaterialProvisionRelatingToStockholdersRightsOrPreInitialBusinessCombinationActivity
1
CY2022Q1 twnd Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
325463
CY2022Q1 twnd Working Capital Deficit
WorkingCapitalDeficit
3584663
CY2021Q4 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30832371
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30832371
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q4 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
334215700
CY2022Q1 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
334215700
CY2021Q4 twnd Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
12700197
CY2022Q1 twnd Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
12700197
CY2021Q4 twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
CY2022Q1 twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1227000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1204000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6493
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.0007
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q1 twnd Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
2
CY2022Q1 twnd Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
2
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q1 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2022Q1 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
2080
CY2022Q1 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334618418
CY2021Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
2040
CY2021Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334439154

Files In Submission

Name View Source Status
0001104659-22-061335-index-headers.html Edgar Link pending
0001104659-22-061335-index.html Edgar Link pending
0001104659-22-061335.txt Edgar Link pending
0001104659-22-061335-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twnd-20220331.xsd Edgar Link pending
twnd-20220331x10q.htm Edgar Link pending
twnd-20220331x10q_htm.xml Edgar Link completed
twnd-20220331xex31d1.htm Edgar Link pending
twnd-20220331xex31d2.htm Edgar Link pending
twnd-20220331xex32d1.htm Edgar Link pending
twnd-20220331xex32d2.htm Edgar Link pending
twnd-20220331_cal.xml Edgar Link unprocessable
twnd-20220331_def.xml Edgar Link unprocessable
twnd-20220331_lab.xml Edgar Link unprocessable
twnd-20220331_pre.xml Edgar Link unprocessable